The fact is CE approval is locked in and we have substantial and rapidly growing revenue locked in.
In parallel the clinical efficiency which has been known for many years (only available in clinics) is now being validated via the Carrick institute for its take home application (Mente autism).
A very over qualified advisory board has just been appointed and their names are on the record for backing it.
what more could you possibly want in the next 6 months honestly if there is one stock that is clear cut its this one.
Most others are miles behind in regulatory hurdles in their respective fields and yet MC's of way more then NTI.
Ill stick to my bottom line here and call it H1 2017 stock to watch and ill leave there. I feel some are going to be very surprised.
Cheers bonkers
The Brains Trust, page-26
-
- There are more pages in this discussion • 14,996 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add XSO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3,021.9 |
Change
24.300(0.81%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 2,997.6 | 3,033.9 | 2,997.6 |
| XSO (ASX) Chart |